Where do UC MSCs come from?

UC MSCs are collected from the umbilical cord, specifically from a gelatinous substance called Wharton's jelly. The umbilical cord is normally discarded after birth. With informed consent from the donor, a small segment of the cord is gently processed in a lab to isolate these cells.

Because the donor is a newborn, these cells are called "perinatal" stem cells. Research indicates they are younger and more primitive than adult stem cells from bone marrow, which contributes to their high proliferation capacity.

What makes UC MSCs unique?

Unlike embryonic stem cells, UC MSCs are not pluripotent—they do not form every cell type. Their primary role is to act as signaling cells that influence the immune system and healing response. They demonstrate three key features:

• Immunomodulation: They reduce excessive inflammation.
• Paracrine signaling: They secrete growth factors that support tissue repair.
• Low immunogenicity: They are not rejected by the recipient's immune system.

How do they work? The paracrine effect

Early research proposed that MSCs homed to injuries and differentiated into missing cell types (such as cartilage cells). Current research demonstrates that very few MSCs remain in the body long-term. Instead, they act through the "paracrine effect"—secreting exosomes and signaling proteins that influence nearby cells.

These signals direct resident cells to reduce inflammation, prevent cell death, and increase tissue repair. UC MSCs function as signaling centers that coordinate the body's natural healing response.

Stem Cell IV Therapy: Foundation of Regenerative Support

Stem Cell IV Therapy serves as a core regenerative approach. The therapy works alongside nutrition and supportive protocols to support the body's natural regenerative potential.

Working with nutrition: The cellular environment influences MSC function. Targeted nutritional support—including specific amino acids, antioxidants, and micronutrients—prepares the cellular landscape for MSC reception. Nutrition conditions the body to be more receptive to the signals MSCs provide.

Extension protocols: The regenerative signaling from MSCs continues after the cells complete their signaling cycle. Extension protocols—including continued nutritional support, lifestyle optimization, and complementary therapies—support and prolong the initial benefits. This extension phase maintains balanced immune environments and supports ongoing tissue remodeling.

Integrated approach: All supplements and adjunct therapies work with the foundational stem cell therapy—preparing the cellular environment before treatment, enhancing MSC activity during the therapeutic window, and extending regenerative benefits through sustained supportive mechanisms.

The Role of Nutrition

Pre-treatment preparation: Nutrients such as curcumin, omega-3 fatty acids, and specific polyphenols modulate inflammation and support cellular health. When introduced before stem cell therapy, they help create an optimal microenvironment for MSC signaling.

During the therapeutic window: The days and weeks following IV administration represent a critical period when MSCs actively release paracrine factors. Nutritional support during this phase provides building blocks for tissue repair processes that MSCs help coordinate.

Extension protocols: Long-term nutritional strategies sustain balanced immune environments and support extracellular matrix remodeling that follows MSC signaling. This extension phase translates temporary signaling events into lasting tissue improvements.

Working relationship: Nutrition works with MSC therapy by providing raw materials and environmental conditions that allow regenerative signaling to be most effective.